A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

Summary

This study will determine the capacity of more frequent dosing of QAV680 to suppress allergic inflammation. The study will investigate the paradigm of multiple receptor antagonism in allergic disease by combining QAV680 with a second generation H1 histamine receptor antagonist to assess possible additive or synergistic anti-allergic effects of the two compound classes.

Timeline

Start

2010-03-22

Primary completion

2010-07-28

Completion

2010-07-28

Drugs

Indications